Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PSCA anticorps

PSCA Reactivité: Humain, Souris WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7254328
  • Antigène Voir toutes PSCA Anticorps
    PSCA (Prostate Stem Cell Antigen (PSCA))
    Reactivité
    • 60
    • 20
    • 10
    • 2
    • 2
    • 2
    Humain, Souris
    Hôte
    • 51
    • 9
    • 1
    Lapin
    Clonalité
    • 53
    • 8
    Polyclonal
    Conjugué
    • 35
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp PSCA est non-conjugé
    Application
    • 48
    • 18
    • 13
    • 13
    • 10
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Attributs du produit
    Polyclonal Antibody
    Purification
    Antigen affinity purification
    Immunogène
    Synthetic peptide of human PSCA
    Isotype
    IgG
    Top Product
    Discover our top product PSCA Anticorps primaire
  • Indications d'application
    WB 1:500-1:2000, IHC 1:20-1:100, ELISA 1:5000-1:10000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.78 mg/mL
    Buffer
    PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène
    PSCA (Prostate Stem Cell Antigen (PSCA))
    Autre désignation
    PSCA (PSCA Produits)
    Synonymes
    anticorps PRO232, anticorps 2210408B04Rik, anticorps PSCA, anticorps prostate stem cell antigen, anticorps PSCA, anticorps Psca, anticorps LOC482068
    Sujet
    PSCA (Prostate Stem Cell antigen) is a cell surface antigen, which is overexpressed in ~40 % of primary prostate cancers and in as many as 100 % of metastatic ones. PSCA is also overexpressed in a majority of transitional cell and pancreatic carcinomas. Antibody directed against PSCA inhibits tumorigenesis, slows tumor growth, prolongs survival and prevents metastasis in a preclinical zenograft model indicating that PSCA may have utility as a prognostic marker and/or therapeutic target in prostate cancer.
    Poids moléculaire

    Observed_MW: Refer to figures

    Calculated_MW: 13 kDa

    UniProt
    O43653
Vous êtes ici:
Support technique